Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial

NCT07703722 is registered in ClinicalTrials.gov with Khyber Medical University Peshawar as lead sponsor.

NCT NCT07703722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07703722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial
Lead sponsor
Khyber Medical University Peshawar
Phase
Phase 3
Overall status
Recruiting
Start date
April 1, 2026
Completion date
November 22, 2027
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, post-traumatic stress disorder (ptsd)